BALDWIN BROTHERS LLC/MA - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BALDWIN BROTHERS LLC/MA ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2023$5,099,708
-4.6%
50,507
-3.8%
0.40%
-12.8%
Q3 2023$5,346,546
+1.6%
52,489
+0.6%
0.46%
+6.5%
Q2 2023$5,263,078
+8.5%
52,156
-1.1%
0.43%
+2.1%
Q1 2023$4,851,635
+1.8%
52,735
+0.4%
0.42%
-2.1%
Q4 2022$4,763,517
+3772.8%
52,508
+3153.3%
0.43%
+2441.2%
Q3 2022$123,000
-9.6%
1,6140.0%0.02%
-5.6%
Q2 2022$136,000
-6.8%
1,614
-2.7%
0.02%
+20.0%
Q1 2022$146,000
-1.4%
1,659
-1.8%
0.02%0.0%
Q4 2021$148,000
-17.3%
1,689
-22.7%
0.02%
-25.0%
Q3 2021$179,000
-6.8%
2,185
+3.6%
0.02%
-4.8%
Q2 2021$192,000
+3.2%
2,109
-3.2%
0.02%
-4.5%
Q1 2021$186,000
+0.5%
2,179
+11.1%
0.02%
-4.3%
Q4 2020$185,000
+8.2%
1,9620.0%0.02%0.0%
Q3 2020$171,000
+3.0%
1,962
+3.4%
0.02%
-4.2%
Q2 2020$166,000
+6.4%
1,8970.0%0.02%
-11.1%
Q1 2020$156,000
-10.9%
1,897
+2.6%
0.03%
+12.5%
Q4 2019$175,000
+10.8%
1,849
+1.8%
0.02%0.0%
Q3 2019$158,000
+690.0%
1,817
+718.5%
0.02%
+700.0%
Q2 2019$20,000
-4.8%
2220.0%0.00%0.0%
Q1 2019$21,000
+10.5%
2220.0%0.00%0.0%
Q4 2018$19,0000.0%2220.0%0.00%0.0%
Q3 2018$19,000
+26.7%
222
+11.0%
0.00%
+50.0%
Q2 2018$15,000
-6.2%
2000.0%0.00%
-33.3%
Q1 2018$16,000
-5.9%
2000.0%0.00%0.0%
Q3 2017$17,0000.0%2000.0%0.00%0.0%
Q2 2017$17,0000.0%200
-14.2%
0.00%0.0%
Q1 2017$17,000
+13.3%
233
+16.5%
0.00%0.0%
Q4 2016$15,000
-31.8%
200
-27.3%
0.00%
-25.0%
Q3 2016$22,000
-99.8%
275
-99.8%
0.00%
-99.8%
Q2 2016$9,257,000
+21.0%
112,196
+6.2%
1.90%
+38.6%
Q1 2016$7,652,000
-7.2%
105,633
+10.2%
1.37%
+2.3%
Q4 2015$8,247,000
-25.8%
95,847
-20.8%
1.34%
-28.4%
Q3 2015$11,121,000
-4.2%
120,984
+2.5%
1.88%
+8.9%
Q2 2015$11,607,000
+0.5%
118,029
+0.7%
1.72%
+1.1%
Q1 2015$11,554,000
-0.9%
117,172
-6.9%
1.70%
+0.9%
Q4 2014$11,663,000
+1.8%
125,872
+3.4%
1.69%
+3.8%
Q3 2014$11,461,000
+9.6%
121,762
+5.4%
1.63%
+4.7%
Q2 2014$10,460,000
+7.1%
115,538
+0.6%
1.55%
-1.0%
Q1 2014$9,765,000
+3.2%
114,855
-2.4%
1.57%
+3.2%
Q4 2013$9,463,000
+1.2%
117,726
-3.4%
1.52%
-11.0%
Q3 2013$9,352,000
-10.4%
121,916
-17.5%
1.71%
-17.3%
Q2 2013$10,443,000147,6932.07%
Other shareholders
NOVARTIS A G shareholders Q4 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders